About Event

2nd Next-Generation Food Allergy Drug Development Summit

Revolutionizing Food Allergy Products to Accelerate Curative Therapies to Market

In 2021, we united 60+ industry leaders actively developing immunotherapies and biologics to treat food allergies more effectively at the inaugural Next-Generation Food Allergy Development Summit.

This year the content will go beyond just the oral immunotherapy approaches, with a greater spotlight being placed on the antibody and microbiome-based strategies, while highlighting the potential of combining modalities to deliver long lasting and effective treatments.

Time is of the essence to join the mission to turn promising food allergy biologics into clinical and commercial realities as the field accelerates into the clinic to meet huge patient need.

Join Your Peers to:

icon 1 investigate

Explore the most recent technological developments, including vaccines, immunotherapies, and antibody and microbiome-based methods

icon 2 community

Streamline your clinical development process, including defining and meeting clinical endpoints and translatability from pre-clinical studies including patient perspectives, and patient eligibility criteria

icon 3 peers

Understand the needs and desires of the patient community by incorporating patient insights into therapeutic development

icon 4 development

Address regulatory, manufacturing and CMC challenges in the development of a reliable and stable food allergy medication

icon 5 connections

Build global connections and benefit from the multiple interactive networking activities and Q&A sessions to expand your current network and build future partnerships

Who Will You Meet?

Bringing together the pioneering trailblazers of industry including Aimmune, ClostraBio, Prota Therapeutics, Angany, IgGenix and more, this unmissable program will deep dive into exciting new delivery approaches, optimal clinical trial design, latest clinical updates and multi-treatment combination strategies to deliver effective and accessible therapeutic avenues.

audience summary